Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - FREE CASH FLOW
Free Cash Flow ALNY - Alnylam Pharmaceuticals, Inc.
-42.6 M
LAST VALUE
73.65%
2 YEAR CAGR
36.69%
5 YEAR CAGR
13.16%
10 YEAR CAGR